Related Experiment Video
Updated: Jun 29, 2025

05:38
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
64
Localised erythema nodosum leprosum-A rare entity managed with thalidomide
Chandni Patel1, Barbara De Barros2,3, Stephen L Walker2,3,4
1Department of Healthcare Services for Elderly People Royal Free Hospital NHS Foundation Trust London UK.
Skin Health and Disease
|April 5, 2024
Summary
Erythema nodosum leprosum (ENL), a severe leprosy complication, typically presents widely. This case highlights a rare localized ENL form successfully treated with thalidomide.
Area of Science:
- Immunology
- Dermatology
- Infectious Diseases
Background:
- Leprosy, caused by *Mycobacterium leprae*, affects skin and nerves.
- Leprosy reactions include Type 1 and Type 2 (erythema nodosum leprosum - ENL).
- ENL is a severe, immune-mediated complication of lepromatous leprosy.
Observation:
- A 29-year-old woman presented with a localized form of ENL.
- This presentation is unusual for ENL, which typically involves widespread symptoms.
- Symptoms included painful cutaneous nodules, fever, and peripheral edema.
Findings:
- The patient's localized ENL required specific treatment for remission.
- Thalidomide was administered to manage the localized ENL.
- The case demonstrates an atypical manifestation of ENL.
Implications:
- This case expands the understanding of ENL clinical presentations.
- It highlights thalidomide as a treatment option for localized ENL.
- Further research into atypical leprosy reactions is warranted.
Related Concept Videos
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162

